Course Overview

DSM-402: Diabetes: Approaches in Disease Management (3 Credits)
Program(s): CMR

COURSE CONSULTANTS

SEVENTH EDITION:

Barry J. Goldstein, MD, PhD
Professor of Medicine
Director, Division of Endocrinology,
Diabetes and Metabolic Diseases
Jefferson Medical College of Thomas Jefferson University
Philadelphia, Pennsylvania

Cindy Wordell, PharmD
Thomas Jefferson University Hospitals
Department of Pharmacy
Philadelphia, Pennsylvania

Graduate Supplement
DSM-5402
To earn graduate-level credit, this supplement and course DSM-402 must be successfully completed.

Click here for more information about graduate-level credit.

Who Should Take This Course:
Sales representatives and managers who interact with healthcare providers who treat patients with diabetes, including primary care physicians, endocrinologists, pharmacists, healthcare organization professionals and administrators, and those with an interest in the comprehensive management of this disease.

Career Applications/Benefits:
Many pharmaceutical companies offer a range of diabetes management services to assist healthcare organizations, including value-added services, diabetes screening services, educational programs, and comprehensive diabetes management programs. This provides healthcare representatives, managers, and others with the opportunity to assist healthcare organizations by making them aware of the menu of services that can be customized to meet each organization’s specific needs. This course will benefit those in pharmaceutical companies that develop or market products related to the treatment of diabetes and its complications. The information provided in the course will help sales representatives and others understand basic concepts and key issues in diabetes treatment and management so that they can knowledgeably discuss these subjects with healthcare professionals.

Course Description:
This course provides information regarding the clinical and economic impact of diabetes and the management strategies being implemented to improve outcomes for patients with diabetes. The course begins with a profile of the disease and its complications, diagnostic procedures, and treatment methods. Next, the course discusses current guidelines for managing patients with diabetes and focuses on preventive measures to reduce the number of hospitalizations and fatalities due to this disease. Examples of how various healthcare organizations and pharmaceutical companies are implementing diabetes management programs are provided, along with a discussion of how these services are offered to healthcare customers.

Related Courses:

Diabetes Virtual Preceptorship
The Managed Healthcare Market
Disease Management
Nutrition: Wellness and Disease
Endocrine System
Outcomes: Measurement, Management, and Marketing
Introduction to Pharmacology

Chapter Content:

Chapter 1: Overview of Diabetes
	Glucose Metabolism and Diabetes Types of Diabetes Complications of Diabetes Screening and Diagnosis of Diabetes Treatment of Diabetes New Treatment Options and Future Directions of Diabetes Therapy Monitoring of Diabetes Economic Impact of Diabetes
Chapter 2: Diabetes Management Guidelines
	Clinical Data in Diabetes Guidelines for Managing Diabetes Special Considerations Prevention or Delay of Diabetes
Chapter 3: Diabetes Management in Healthcare Organizations
	Diabetes Management Programs Outcomes Assessment
Chapter 4: Role of the Pharmaceutical Industry in Diabetes Management
	Relationships with Healthcare Systems Types of Diabetes Management Services Role of the Healthcare Representative

Learning Objectives:
Upon successful completion of this course, the student will be able to describe the epidemiology, pathophysiology, causative factors, treatment options, and economic impact of both type 1 (insulin-dependent diabetes mellitus), and type 2 (non-insulin-dependent diabetes mellitus); discuss current clinical practice guidelines for managing patients with diabetes; discuss the implementation of diabetes management programs by employers, insurers, and healthcare organizations; and describe the types of diabetes management programs being developed by various pharmaceutical companies, including opportunities for healthcare representatives.